Breath Gases, Gut Flora, and Immunity in Children With Constipation
Correlation Study on End-expiratory NO, H2S, H2, CH4, Intestinal Flora and Immune Function in Children With Constipation
Constipation is a common problem in children that can affect their daily life, school performance, and social activities. Researchers have found that the bacteria living in our intestines (called "gut microbiome") may play an important role in constipation. However, we still do not fully understand exactly how these bacteria affect constipation in children.
This study aims to explore whether the gases children breathe out-including nitric oxide (NO), hydrogen sulfide (H₂S), hydrogen (H₂), and methane (CH₄)-can tell us something about the bacteria in their guts. By comparing children with constipation to healthy children, we hope to find out:
Whether the gases in their breath are different Whether the types of bacteria in their guts are different Whether there is a relationship between breath gases and gut bacteria If we find clear connections, this could lead to a simple, non-invasive breath test that doctors can use to understand a child's gut health without the need for more invasive procedures.
研究概览
地位
条件
详细说明
Childhood functional constipation (FC) is a multifactorial syndrome with a global prevalence of approximately 9.5% among pediatric populations, accounting for up to 29% of functional gastrointestinal disorders. It significantly affects physical health, academic performance, and psychosocial development, with approximately 25% of affected children continuing to experience gastrointestinal symptoms into adulthood. While conventional factors such as diet, fluid intake, and psychological stress have been implicated, the precise pathophysiological mechanisms remain incompletely understood.
Emerging evidence highlights the critical role of the gut microbiome in regulating intestinal motility and visceral sensitivity through the microbiota-gut-brain axis. Microbial metabolites-including short-chain fatty acids (SCFAs), serotonin, bile acids, and gases (methane, hydrogen, hydrogen sulfide)-serve as key signaling molecules that influence enteric neurotransmission, smooth muscle contraction, and gastrointestinal transit time. Notably, hydrogen (H₂) and methane (CH₄) are exclusively of microbial origin (produced via anaerobic fermentation of carbohydrates by intestinal flora), while hydrogen sulfide (H₂S) is generated both endogenously and by sulfate-reducing bacteria. Nitric oxide (NO), though primarily endogenously produced, may also reflect intestinal inflammatory status and microbial metabolic activity.
The integration of breath gas analysis and metagenomic profiling offers a promising, non-invasive approach to elucidate host-microbe interactions in FC. However, systematic evaluations linking these four exhaled gases (NO, H₂S, H₂, CH₄) to the taxonomic and functional composition of the gut microbiome in constipated children remain scarce. This study is designed to bridge this knowledge gap, providing mechanistic insights and potentially establishing breath testing as a surrogate marker for gut dysbiosis in pediatric constipation.
研究类型
注册 (估计的)
联系人和位置
学习地点
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国、200025
- Ruijin Hospital
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Children aged 6 to 14 years, male or female.
- Legal guardian provides written informed consent.
- No use of antibiotics, probiotics, lactulose, antacids, or gastrointestinal prokinetic agents within 4 weeks prior to enrollment.
- For the constipation group: Clinical diagnosis of functional constipation according to Rome criteria, defined as meeting at least two of the following criteria for two consecutive months: (a) fewer than two bowel movements per week; (b) at least one episode of fecal incontinence per week; (c) history of massive fecal retention or posturing related to fecal retention; (d) history of painful or difficult defecation; (e) presence of a large fecal mass in the rectum; (f) passage of stools large enough to obstruct the toilet. Additionally, no enema or acute enteritis within 2 weeks prior to enrollment.
- For the healthy control group: No chronic digestive diseases or acute illnesses; no enema or acute enteritis within 2 weeks prior to enrollment.
Exclusion Criteria:
- Use of antibiotics, probiotics, lactulose, antacids, or gastrointestinal prokinetic agents within 4 weeks prior to enrollment (if not already excluded at screening).
- Clinically significant abnormalities in liver, kidney, neurological, respiratory, or coagulation function as determined by the investigator.
- Unstable vital signs.
- Presence of other underlying systemic diseases (e.g., metabolic, endocrine, or organic gastrointestinal disorders).
- Any other condition that, in the investigator's opinion, makes the participant unsuitable for enrollment.
学习计划
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
|---|
|
Constipation Group
Children aged 6 to 14 years diagnosed with functional constipation according to Rome criteria (at least two of the following for two consecutive months: fewer than two bowel movements per week; at least one episode of fecal incontinence per week; history of massive fecal retention or posturing related to fecal retention; history of painful or difficult defecation; presence of a large fecal mass in the rectum; passage of stools large enough to obstruct the toilet).
Participants have not used antibiotics, probiotics, lactulose, antacids, or prokinetic agents within 4 weeks prior to enrollment, and have not received enema or had acute enteritis within 2 weeks.
Intervention: Non-interventional; participants undergo a one-time breath test (end-expiratory NO, H₂S, H₂, CH₄), stool collection (within 2 days), and blood draw (2 mL).
|
|
Control Group
Healthy children aged 6 to 14 years with no chronic digestive diseases or acute illnesses, recruited from routine health check-up visits.
Participants have not used antibiotics, probiotics, lactulose, antacids, or prokinetic agents within 4 weeks prior to enrollment.
Intervention: Non-interventional; participants undergo a one-time breath test (end-expiratory NO, H₂S, H₂, CH₄), stool collection (within 2 days), and blood draw (2 mL).
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
End-expiratory concentrations and peak values of H2
大体时间：Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
Comparison of the fasting end-expiratory concentrations (ppm) and peak values of hydrogen (H2) between children with functional constipation and healthy controls.
Breath samples are collected during a single morning session after an overnight fast using a validated portable breath analyzer.
|
Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
End-expiratory concentrations and peak values of H2S
大体时间：Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
Comparison of the fasting end-expiratory concentrations (ppm) and peak values of hydrogen sulfide (H2S) between children with functional constipation and healthy controls.
Breath samples are collected during a single morning session after an overnight fast using a validated portable breath analyzer.
|
Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
|
End-expiratory concentration and peak value of methane (CH₄)
大体时间：Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
Comparison of fasting end-expiratory CH₄ concentration (ppm) and peak values between children with functional constipation and healthy controls.
CH₄ is exclusively produced by methanogenic archaea in the gut and is not metabolized by mammalian cells.
Elevated CH₄ levels (e.g., ≥10 ppm) are associated with prolonged colonic transit time and increased constipation severity.
The analysis will compare intergroup differences in both baseline concentration and maximum peak values during the breath test.
|
Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
|
End-expiratory concentration and peak value of nitric oxide (NO)
大体时间：Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
Comparison of fasting end-expiratory NO concentration (ppb) and peak values between children with functional constipation and healthy controls.
End-expiratory NO reflects systemic and intestinal inflammatory status.
Alterations in NO levels may indicate mucosal barrier dysfunction or low-grade inflammation associated with constipation.
The analysis will compare intergroup differences in both baseline concentration and maximum peak values.
|
Measured at baseline (single time point) after an overnight fast, during a single methane-hydrogen breath test session.
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Fecal metabolomic profiles
大体时间：Within 2 days after the breath test (baseline)
|
Identification and comparison of untargeted fecal metabolomic profiles via LC-MS/MS between constipated children and healthy controls.
Differential metabolites and enriched KEGG metabolic pathways will be identified.
|
Within 2 days after the breath test (baseline)
|
|
serum gastrointestinal hormone levels
大体时间：At the single study visit (baseline)
|
Comparison of serum levels of gastrointestinal hormones (e.g., motilin) and routine blood parameters between the two groups.
Blood samples (2 mL) are drawn at enrollment and processed via ELISA and automated hematology analyzers.
|
At the single study visit (baseline)
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- C001
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.